Christopher Darlow
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Neonatal and Maternal Infections 5
- Co-authors
- William Hope (11 shared papers)Pieter Pretorius (1 shared paper)Philippa C. Matthews (1 shared paper)Nicola Jones (1 shared paper)Shampa Das (7 shared papers)Richard Kerr (1 shared paper)Sarah Oakley (1 shared paper)F. Franceschi (4 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Infection (1 paper)Infection (1 paper)CPT Pharmacometrics & Systems Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Christopher Darlow
15 papers receiving 192 citations
Peers
Comparison fields: 5 of 44
- Applied Microbiology and Biotechnology 19
- Molecular Medicine 47
- Microbiology 37
- Pharmacology 65
- Microbiology 2
Countries citing papers authored by Christopher Darlow
This map shows the geographic impact of Christopher Darlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Darlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Darlow more than expected).
Fields of papers citing papers by Christopher Darlow
This network shows the impact of papers produced by Christopher Darlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Darlow. The network helps show where Christopher Darlow may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Darlow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 45 | |
| 2 | 2021 | 37 | |
| 3 | 2021 | 28 | |
| 4 | 2017 | 21 | |
| 5 | 2021 | 16 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 8 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 7 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2017 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 0 |
About Christopher Darlow
Christopher Darlow is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology and Molecular Medicine, having authored 16 papers that have together received 194 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Neonatal and Maternal Infections (5 papers), Antibiotic Resistance in Bacteria (3 papers), Bacterial Infections and Vaccines (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Salmonella and Campylobacter epidemiology (1 paper), Antifungal resistance and susceptibility (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (19 citations), Molecular Medicine (47 citations), Microbiology (37 citations), Pharmacology (65 citations) and Microbiology (2 citations). Christopher Darlow has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include William Hope, Pieter Pretorius, Philippa C. Matthews, Nicola Jones, Shampa Das, Richard Kerr, Sarah Oakley, F. Franceschi, Laura J. V. Piddock and Mike Sharland. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Journal of Infection, Infection and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.